Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra Issues URGENT Worldwide Recall of NeuroBalloon™ Catheter
Integra Issues URGENT Worldwide Recall of NeuroBalloon™ Catheter Integra LifeSciences Corporation, Plainsboro, New Jersey, has initiated a worldwide recall of the NeuroBalloon Catheter. There were a total of 1,924 units distributed, 258 in the United States of America 1,586 in the European
View HTML
Toggle Summary Integra LifeSciences Introduces the iPASSAGE(TM) Retractor for Minimally Invasive Spine Surgery
PLAINSBORO, N.J., Aug. 13, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the addition of the iPASSAGE TM Retractor for Minimally Invasive Surgery (MIS) of the lumbar spine. The iPASSAGE TM Retractor is a tissue sparing retraction system that allows
View HTML
Toggle Summary Integra LifeSciences Announces Three-Year Contract with GPO Amerinet to Provide JARIT(R) Surgical Instruments
PLAINSBORO, N.J., Aug. 12, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it signed a three-year contract for JARIT® surgical instruments with Amerinet, a leading national healthcare group purchasing organization (GPO).
View HTML
Toggle Summary Integra LifeSciences Establishes New $600 Million Senior Secured Credit Facility
Integra Establishes a $450 Million 5-Year Revolver and a $150 Million 5-Year Term Loan A Integra Reiterates Earnings Per Share Guidance for 2010 PLAINSBORO, N.J., Aug. 10, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has established a $450
View HTML
Toggle Summary Integra LifeSciences to Present at BMO Capital Markets 10th Annual Focus on Healthcare Conference and Canaccord Genuity Global Healthcare Conference
PLAINSBORO, N.J., July 30, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two conferences in August. On Thursday, August 5th, 2010 at 8:30 am ET, Mr. Gerry Carlozzi, Executive Vice President and Chief Operating Officer of
View HTML
Toggle Summary Integra LifeSciences Reports Second Quarter 2010 Financial Results
Revenues Increase 8% to $179 Million
View HTML
Toggle Summary Integra LifeSciences Introduces DuraGen Plus(R) Dural Regeneration Matrix - Spinal Matrix, for Repair of the Dura
PLAINSBORO, N.J., July 9, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of DuraGen Plus® Dural Regeneration Matrix - Spinal Matrix, an absorbable and sutureless collagen onlay indicated as a dura substitute for the repair of dura mater.
View HTML
Toggle Summary Integra LifeSciences to Host Its Second Quarter 2010 Earnings Results Conference Call on July 29, 2010
PLAINSBORO, N.J., July 6, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will release its second quarter 2010 financial results on Thursday, July 29, 2010. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
View HTML
Toggle Summary Linda Littlejohns of Integra LifeSciences Chosen as 2010 Fellow of the American Academy of Nursing
PLAINSBORO, N.J., June 30, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Linda Littlejohns RN MSN CCRN CNRN, Vice President, Clinical Development at Integra, has been selected as a Fellow of the American Academy of Nursing, one of the most
View HTML
Toggle Summary Integra LifeSciences Reaches Milestone of Over 800 Implanted Vu a-POD(TM) Devices
PLAINSBORO, N.J., June 8, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq:IART) announced today a major milestone in the commercialization of the Vu a-POD™ anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod™ fusion device has now been
View HTML